Harry S. Winchell
23Patents
9h-index
15Co-inventors
72Inventor score
Filing activity: May 14, 1973 → Jun 13, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5874573A | Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy | Chemistry; Metallurgy | 48 | Expired |
| US4079124A | Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten | Human Necessities | 32 | Expired |
| US4279887A | Amides useful as brain imaging agents | Chemistry; Metallurgy | 22 | Expired |
| US4360511A | Amines useful as brain imaging agents | Chemistry; Metallurgy | 22 | Expired |
| US4364920A | Stable diagnostic reagents | Human Necessities | 21 | Expired |
| US5236695A | MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5409689A | MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms | Emerging Cross-Sectional Technologies | 14 | Expired |
| US3957033A | Ventilation study system | Human Necessities | 10 | Expired |
| US6264966A | Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury | Human Necessities | 9 | Expired |
| US6387891B2 | COMPOUNDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS AND THEIR USE IN COSMETICS AND PERSONAL CARE PRODUCTS, INHIBITION OF METALLOENZYMES, AND INHIBITION OF REPERFUSION INJURY | Human Necessities | 8 | Expired |
| US4233285A | Mercaptocarboxylic acid radiopharmaceuticals | Human Necessities | 8 | Expired |
| US4001387A | Process for preparing radiopharmaceuticals | Physics | 8 | Expired |
| US4176173A | Radiographic compositions | Chemistry; Metallurgy | 8 | Expired |
| US4024233A | 99M-technetium labeled macroaggregated human serum albumin pharmaceutical | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5593659A | MRI image enchancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6583182B1 | Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis | Chemistry; Metallurgy | 7 | Expired |
| US3981769A | Process for preparing fluorine-18 | Physics | 6 | Expired |
| US5380515A | MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonated ligands | Emerging Cross-Sectional Technologies | 6 | Expired |
| US3968221A | 99M-Technetium labeled tin colloid radiopharmaceuticals | Human Necessities | 5 | Expired |
| US6469162B1 | Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis | Chemistry; Metallurgy | 3 | Expired |
| US6881732B2 | Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements | Human Necessities | 2 | Expired |
| US6165996A | Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis | Chemistry; Metallurgy | 1 | Expired |
| US6576760B2 | Processes for synthesis of cyclic and linear polyamine chelators containing N-monosubstituted coordinating arms | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.